Identification of new drug targets and biomarkers related to obesity and eating disorders: An approach based on reward deficit and addiction

Current Pharmaceutical Design

Volumn 17, Issue 5, 2011, Pages 462-470

  Alguacil, Luis F ^a,b   Salas, Elisabet ^a   González Martín, Carmen ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

^b UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Addiction; Eating disorders; Obesity; Reward deficit

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMPHETAMINE; BIOLOGICAL MARKER; COCAINE; FLAVOPROTEIN; FUMARATE HYDRATASE; GHRELIN; GLUTATHIONE TRANSFERASE; INSULIN; LEPTIN; PEROXIREDOXIN 5; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TRANSKETOLASE; UBIQUINONE;

ANOREXIA; ARTICLE; BINGE EATING DISORDER; BULIMIA; DIET RESTRICTION; DRUG DEPENDENCE; DRUG USE; FEEDING BEHAVIOR; FOOD INTAKE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ASSOCIATION; OBESITY; PHYSICAL ACTIVITY; PHYSICAL STRESS; PRIORITY JOURNAL; REWARD; SHAM FEEDING; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; DISEASE MODELS, ANIMAL; EATING DISORDERS; GENOMICS; HUMANS; MODELS, NEUROLOGICAL; MOLECULAR TARGETED THERAPY; NEURAL PATHWAYS; OBESITY; PROTEOMICS; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 79953304305     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161211795164158     Document Type: Article

References (99)

1. Bessesen DH. Update on obesity. J Clin Endocrinol Metab 2008; 93: 2027-34.
2. Hainer V, Toplak H, Mitrakou A. Treatment modalities of obesity: what fits whom? Diabetes Care 2008; 31 (Suppl 2): S269-77.
3. Taylor D. Withdrawal of Rimonabant--walking the tightrope of 21st century pharmaceutical regulation? Curr Drug Saf 2009; 4:2-4.
4. Scheen AJ. Cardiovascular risk-benefit profile of sibutramine. Am J Cardiovasc Drugs 2010; 10: 321-34.
5. McClendon KS, Riche DM, Uwaifo GI. Orlistat: current status in clinical therapeutics. Expert Opin Drug Saf 2009; 8: 727-44.
6. Ramoz N, Versini A, Gorwood P. Eating disorders: an overview of treatment responses and the potential impact of vulnerability genes and endophenotypes. Expert Opin Pharmacother 2007; 8: 2029-44.
7. García-Camba E, Gómez-Oliver F. In: Lorenzo P, et al. Ed. Velázquez-Farmacología Básica y Clínica. Madrid: Editorial Médica Panamericana 2008; pp.
8. Monteleone P, Maj M. Genetic susceptibility to eating disorders: associated polymorphisms and pharmacogenetic suggestions. Pharmacogenomics 2008; 9: 1487-520.
9. Corsica JA, Pelchat ML. Food addiction: true or false? Curr Opin Gastroenterol 2010; 26:165-9.
10. Olds J, Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 1954; 47: 419-27.
11. Blum K, Sheridan PJ, Wood RC, et al. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med 1996; 89: 396-400.
12. Blum K, Chen AL, Braverman ER, et al. Attention-deficithyperactivity disorder and reward deficiency syndrome. Neuropsychiatr Dis Treat 2008; 4: 893-918.
13. Figlewicz DP, Evans SB, Murphy J, Hoen M, Baskin DG. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res 2003; 964: 107-15.
14. Krügel U, Schraft T, Kittner H, Kiess W, Illes P. Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin. Eur J Pharmacol 2003; 482: 185-7.
15. Abizaid A, Liu ZW, Andrews ZB, et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 2006; 116: 3229-39.
16. Palmiter RD. Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 2007; 30: 375-81.
17. Zheng H, Berthoud HR. Eating for pleasure or calories. Curr Opin Pharmacol 2007; 7: 607-12.
18. Benoit SC, Davis JF, Davidson TL. Learned and cognitive controls of food intake. Brain Res 2010; 1350: 71-6.
19. Nutt DJ. Addiction: brain mechanisms and their treatment implications. Lancet 1996; 6: 31-6.
20. Wolf ME. Addiction: Making the connection between behavioral changes and neuronal plasticity in specific pathways. Molecular Interventions 2002; 2: 146-57.
21. Colado I, Alguacil LF. In: Lorenzo P, et al. Ed. VelázquezFarmacología Básica y Clínica. Madrid: Editorial Médica Panamericana 2008; pp. 335-353.
22. Schultz W. Behavioral theories and the neurophysiology of reward. Annu Rev Psychol 2006; 57: 87-115.
23. Fallon S, Shearman E, Sershen H, Lajtha A. Food reward-induced neurotransmitter changes in cognitive brain regions. Neurochem Res 2007; 32: 1772-82.
24. Nestler EJ. Is there a common molecular pathway for addiction? Nat Neurosci 2005; 8: 1445-9.
25. Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev Neurosci 2007; 8: 844-58.
26. González-Martín C, Fole A, Huarte C, Alguacil LF, Del Olmo N. Cambios morfológicos en el hipocampo tras la exposición crónica a cocaína en ratas Fischer-344. Proceedings of the XIII Congress of the Spanish Society of Neuroscience, 2009 Sep 16-19; Tarragona, Spain. Sociedad Española de Neurociencia 2009; pp. 206-7.
27. Robinson TE, Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nuccleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 1999; 11: 1598-1604.
28. Zahm DS. Pharmacotherapeutic approach to the treatment of addiction: persistent challenges. Mo Med 2010; 107: 276-80.
29. Frank GK, Bailer UF, Henry SE, et al. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biol Psychiatry 2005;58: 908-12.
30. Wagner A, Aizenstein H, Venkatraman VK, et al. Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry 2007; 164: 1842-9.
31. Wagner A, Aizenstein H, Venkatraman VK, et al. Altered striatal response to reward in bulimia nervosa after recovery. Int J Eat Disord. 2010; 43: 289-94.
32. Kaye WH, Ebert MH, Raleigh M, Lake R. Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch General Psychiatry 1984; 41: 350-5.
33. Kaye WH, Frank GK, McConaha C. Altered dopamine activity after recovery from restricting-type anorexia nervosa. Neuropsychopharm 1999; 21: 503-6.
34. Wolfe WL, Maisto SA. The relationship between eating disorders and substance use: moving beyond co-prevalence research. Clin Psychol Rev 2000; 20: 617-31.
35. Root TL, Pinheiro AP, Thornton L, et al. Substance use disorders in women with anorexia nervosa. Int J Eat Disord. 2010; 43: 14-21.
36. Hofker M, Wijmenga C. A supersized list of obesity genes. Nat Genet 2009; 41: 139-40.
37. Thorleifsson G, Walters GB, Gudbjartsson DF, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009; 41: 18-24.
38. Willer CJ, Speliotes EK, Loos RJ, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009; 41: 25-34.
39. Kinzl JF, Schrattenecker M, Traweger C, Mattesich M, Fiala M Biebl W. Psychosocial predictors of weight loss after bariatric surgery. Obes Surg 2006; 16: 1609-14.
40. Odom J, Zalesin KC, Washington TL, et al. Behavioral predictors of weight regain after bariatric surgery. Obes Surg. 2010; 20: 34956.
41. Botella Romero F, Alfaro Martínez JJ, Molina Pacheco E, et al. Influence of previous psychiatric disorders on postoperative course in patients undergoing bariatric surgery. Endocrinol Nutr 2010; 57: 9-15.
42. Davis CA, Levitan RD, Reid C, et al. Dopamine for wanting and opioids for liking: a comparison of obese adults with and without binge eating. Obesity (Silver Spring) 2009; 17: 1220-5.
43. Spitzer RL, Yanovski S, Wadden T, et al. Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 1993; 13: 137-53.
44. Yanovski SZ, Nelson JE, Dubbert BK, Spitzer RL. Association of binge eating disorder and psychiatric comorbidity in obese subjects. Am J Psychiatry 1993; 150: 1472-9.
45. Stunkard AJ, Allison KC. Binge eating disorder: disorder or marker? Int J Eat Disord. 2003;;34 (Suppl): S107-S116.
46. Volkow ND, O'Brien CP.Issues for DSM-V: should obesity be included as a brain disorder? Am J Psychiatry 2007; 164: 708-10.
47. Feltenstein MW, See RE. The neurocircuitry of addiction: an overview. Br J Pharmacol 2008; 154: 261-74.
48. Blumenthal DM, Gold MS. Neurobiology of food addiction. Curr Opin Clin Nutr Metab Care 2010; 13:359-65.
49. Pelchat ML. Food addiction in humans. J Nutr 2009; 139: 620-2.
50. Dagher A. The neurobiology of appetite: hunger as addiction. Int J Obes. 2009; 33 (Suppl 2):S30-3.
51. Wang GJ, Volkow ND, Thanos PK, Fowler JS. Imaging of brain dopamine pathways: implications for understanding obesity. J Addict Med. 2009; 3: 8-18.
52. Passamonti L, Rowe JB, Schwarzbauer C, Ewbank MP, von dem Hagen E, Calder AJ. Personality predicts the brain's response to viewing appetizing foods: the neural basis of a risk factor for overeating. J Neurosci. 2009; 29: 43-51.
53. Wang GJ, Volkow ND, Felder C, et al. Enhanced resting activity of the oral somatosensory cortex in obese subjects. Neuroreport 2002; 13: 1151-55.
54. Barry D, Clarke M, Petry NM. Obesity and Its Relationship to Addictions: Is Overeating a Form of Addictive Behavior? Am J Addict. 2009; 18: 439-51.
55. Nair SG, Adams-Deutsch T, Epstein DH, Shaham Y. The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking. Prog Neurobiol. 2009; 89: 18-45.
56. Anderzhanova E, Covasa M, Hajnal A. Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status. Am J Physiol Regul Integr Comp Physiol 2007; 293: R603-11.
57. Geiger BM, Haburcak M, Avena NM, Moyer MC, Hoebel BG Pothos EN. Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity. Neuroscience 2009; 159: 1193-9.
58. Davis JF, Tracy AL, Schurdak JD, et al. Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat. Behav Neurosci 2008; 122: 1257-63.
59. Alguacil LF, Stucchi P, Olmo N, Herradón G, Ruiz-Gayo M. Biomarkers and drug targets in addiction and obesity. Eur J Clin Pharmacol 2010; 66 (Suppl): S85.
60. Chen PS, Yang YK, Yeh TL, et al. Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers--a SPECT study. Neuroimage 2008; 40: 275-9.
61. Jia JJ, Tian YB, Cao ZH, et al. The polymorphisms of UCP1 genes associated with fat metabolism, obesity and diabetes. Mol Biol Rep 2010; 37: 1513-22.
62. Chaput JP, Tremblay A. Obesity and physical inactivity: the relevance of reconsidering the notion of sedentariness. Obes Facts 2009; 2: 249-54.
63. Ambrosio E, Alguacil LF, Iglesias V, García-Lecumberri C, Crespo JA. Metodologías actuales para el estudio experimental de la drogadicción: una evaluación crítica. Farmacología SNC 1995; 9: 139-59.
64. Rodriguez Parkitna JM, Bilecki W, Mierzejewski P, et al. Effects of morphine on gene expression in the rat amygdala. J Neurochem 2004; 91: 38-48.
65. Lull ME, Erwin MS, Morgan D, Roberts CS, Vrana KE, Freeman WM. Persistent proteomic alterations in the medial prefrontal cortex with abstinence from cocaine self-administration. Proteomics Clin Appl. 2009; 3: 462-72.
66. Tannu NS, Howell LL, Hemby SE. Integrative proteomic analysis of the nucleus accumbens in rhesus monkeys following cocaine self-administration. Mol Psychiatry 2010; 15: 185-203.
67. Salas E, Bocos C, Morales L, et al. Genomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction. FENS Abstr 2008; 4: 086.37.
68. del Castillo C, Morales L, Alguacil LF, et al. Proteomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction. Neuropharmacology 2009; 57: 41-8.
69. Ho MK, Goldman D, Heinz A, et al. Breaking barriers in the genomics and pharmacogenetics of drug addiction. Clin Pharmacol Ther 2010; 88: 779-91.
70. Corwin RL, Buda-Levin A. Behavioral models of binge-type eating. Psysiol Behav 2004; 82: 123-30.
71. Avraham Y, Dagon Y, Magen I, Berry EM. Models of anorexia. Drug Discovery Today: Disease Models Metabolic disorders 2005; 2: 197-204.
72. Casper RC, Sullivan EL, Tecott L. Relevance of animal models to human eating disorders and obesity. Psychopharmacology (Berl). 2008; 199:313-29.
73. Shimizu N, Oomura Y, Kai Y. Stress-induced anorexia in ratsmediated by serotonergic mechanisms in the hypothalamus. Physiol Behav 1989; 46: 835 41.
74. Hao S, Avraham Y, Bonne O, Berry EM. Separation-induced body weight loss, impairment in alternation behavior, and autonomic tone: effects of tyrosine. Pharmacol Biochem Behav 2001; 68: 273-81.
75. Ingram DK, Weindruch R, Spangler EL, Freeman JR, Walford RL. Dietary restriction benefits learning and motor performance of aged mice. J Gerontol 1987; 42: 78-81.
76. Routtenberg A, Kuznesof AW. Self-starvation of rats living in activity wheels on a restricted feeding schedule. J Comp Physiol Psychol, 64: 414-21.
77. Johansen JE, Fetissov S, Fischer H, Arvidsson S, Hökfelt T Schalling M. Approaches to anorexia in rodents: focus on the anx/anx mouse. Eur J Pharmacol 2003;480: 171-6.
78. Klump KL, Gobrogge KL. A review and primer of molecular genetic studies of anorexia nervosa. Int J Eat Disord 2005; 37 (Suppl): S43-8.
79. Morley JE, Levine AS, Rowland NE. Minireview. Stress induced eating. Life Sci 1983; 32: 2169-82.
80. Iwasaki S, Inoue K, Kiriike N, Hikiji K. Effect of maternal separation on feeding behavior of rats in later life. Physiol Behav 2000; 70: 551-6.
81. Hagan MM, Wauford PK, Chandler PC, Jarrett LA, Rybak RJ Blackburn K. A new animal model of binge eating: key synergistic role of past caloric restriction and stress. Physiol Behav 2002; 77: 45-54.
82. Corwin RL, Wojnicki FH, Fisher JO, Dimitriou SG, Rice HB Young MA. Limited access to a dietary fat option affects ingestive behavior but not body composition in male rats. Physiol Behav 1998; 65: 545-53.
83. Mook D. Oral and postingestional determinants of the intake of various solutions in rats with oesophageal fistulas. J Comp Physiol Psychol 1963; 56: 645-9.
84. Wilson JF, Cantor MB. An animal model of excessive eating: schedule-induced hyperphagia in food-satiated rats. J Exp Anal Behav 1987; 47: 335-46.
85. Pinheiro AP, Bulik CM, Thornton LM, et al. Association Study of 182 Candidate Genes in Anorexia Nervosa. Am J Med Genet B Neuropsychiatr Genet. 2010; 153B: 1070-1080.
86. Helder SG, Collier DA. The genetics of eating disorders. Curr Top Behav Neurosci. 2011; 6: 157-75.
87. Speakman J, Hambly C, Mitchell S, Król E. The contribution of animal models to the study of obesity. Lab Animals 2008; 42: 413-32.
88. Pothos EN, Creese I, Hoebel BG. Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. J Neurosci 1995; 15: 6640-50.
89. Cadoni C, Solinas M, Valentini V, Di Chiara G. Selective psychostimulant sensitization by food restriction: differential changes in accumbens shell and core dopamine. Eur J Neurosci 2003; 18: 2326-34.
90. Szczypka MS, Kwok K, Brot MD, et al. Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice. Neuron 2001; 30: 819-28.
91. Small DM, Jones-Gotman M, Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage 2003; 19: 1709-15.
92. Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiol Behav 2008; 94: 121-35.
93. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010; 363: 2339-50.
94. Chalkley R. Instrumentation for LC-MS/MS in proteomics. Methods Mol Biol. 2010; 658: 47-60.
95. Jacob RJ. Bioinformatics for LC-MS/MS-based proteomics. Methods Mol Biol. 2010; 658: 61-91.
96. Katagiri T, Hatano N, Aihara M, et al. Proteomic analysis of proteins expressing in regions of rat brain by a combination of SDSPAGE with nano-liquid chromatography quadrupole-time of flight tandem mass spectrometry. Proteome Science 2010, 8: 41.
97. Plazas-Mayorca MD, Vrana KE. Proteomic investigation of epigenetics in neuropsychiatric disorders: A missing link between genetics and behavior? J Proteome Res.2011; 10: 58-65
98. Franks PW, Ling C. Epigenetics and obesity: the devil is in the details. BMC Med. 2010; 21,8: 88.
99. Campbell IC, Mill J, Uher R, Schmidt U. Eating disorders, geneenvironment interactions and epigenetics. Neurosci Biobehav Rev. 2011; 35: 784-93.